Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Brosman

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
Cancer Research|January 1, 1976
Critical evaluation of lymphocyte functions in urological cancer patientsM M Elhilali, K D Paika, S Brosman, et al.
Urology|July 1, 1979
Idiopathic calcinosis of scrotumD T King, S Brosman, F M Hirose, et al.
Journal of the National Cancer Institute|November 1, 1975
Defective monocyte function in patients with genitourinary carcinomaM S Hausman, S Brosman, R Snyderman, et al.
Cancer Research|November 1, 1981
Depression of the generation of cell-mediated cytotoxicity by macrophage-like suppressor cells in bladder carcinoma patientsC A Spina, F Dorey, C Vescera, et al.
The Journal of Urology|February 25, 2000
Efficacy and safety of valrubicin for the treatment of Bacillus Calmette-Guerin refractory carcinoma in situ of the bladder. The Valrubicin Study GroupG Steinberg, R Bahnson, S Brosman, et al.
Urology|May 1, 1989
Intravesical bacillus Calmette-Guérin and second primary malignanciesP Guinan, S Brosman, J DeKernion, et al.
Urology|December 1, 1991
Long-term complete remission in bladder carcinoma in situ with intravesical TICE bacillus Calmette Guerin. Overview analysis of six phase II clinical trialsR De Jager, P Guinan, D Lamm, et al.
Progress in Clinical and Biological Research|January 1, 1989
Complications of Bacillus Calmette-Guerin immunotherapy: review of 2602 patients and comparison of chemotherapy complicationsD L Lamm, A Steg, L Boccon-Gibod, et al.
British Journal of Cancer|April 20, 2001
Novel erythropoiesis stimulating protein (NESP) for the treatment of anaemia of chronic disease associated with cancerR E Smith, I A Jaiyesimi, L A Meza, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Cancer Research|January 1, 1976
Critical evaluation of lymphocyte functions in urological cancer patientsM M Elhilali, K D Paika, S Brosman, et al.
Urology|July 1, 1979
Idiopathic calcinosis of scrotumD T King, S Brosman, F M Hirose, et al.
Journal of the National Cancer Institute|November 1, 1975
Defective monocyte function in patients with genitourinary carcinomaM S Hausman, S Brosman, R Snyderman, et al.
Cancer Research|November 1, 1981
Depression of the generation of cell-mediated cytotoxicity by macrophage-like suppressor cells in bladder carcinoma patientsC A Spina, F Dorey, C Vescera, et al.
The Journal of Urology|February 25, 2000
Efficacy and safety of valrubicin for the treatment of Bacillus Calmette-Guerin refractory carcinoma in situ of the bladder. The Valrubicin Study GroupG Steinberg, R Bahnson, S Brosman, et al.
Urology|May 1, 1989
Intravesical bacillus Calmette-Guérin and second primary malignanciesP Guinan, S Brosman, J DeKernion, et al.
Urology|December 1, 1991
Long-term complete remission in bladder carcinoma in situ with intravesical TICE bacillus Calmette Guerin. Overview analysis of six phase II clinical trialsR De Jager, P Guinan, D Lamm, et al.
Progress in Clinical and Biological Research|January 1, 1989
Complications of Bacillus Calmette-Guerin immunotherapy: review of 2602 patients and comparison of chemotherapy complicationsD L Lamm, A Steg, L Boccon-Gibod, et al.
British Journal of Cancer|April 20, 2001
Novel erythropoiesis stimulating protein (NESP) for the treatment of anaemia of chronic disease associated with cancerR E Smith, I A Jaiyesimi, L A Meza, et al.
Pageof 3